Search

Displaying results 5581 - 5590 of 10000 in total
  1. Drug

    TPI-ASM8

    go.drugbank.com/drugs/DB05572
    Investigational

    TPI-ASM8 was under investigation in clinical trials NCT00822861, NCT01158898, NCT00402948, and NCT00550797, all for the treatment of Asthma.

  2. Drug

    Tangerine peel

    go.drugbank.com/drugs/DB14316
    Investigational

    Tangerine peel is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    Coconut oil

    go.drugbank.com/drugs/DB14322
    Investigational

    Coconut oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Sunflower oil

    go.drugbank.com/drugs/DB14329
    Investigational

    Sunflower oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  5. Drug

    Chondrus crispus

    go.drugbank.com/drugs/DB14367
    Investigational

    Chondrus crispus is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Agrostis gigantea top

    go.drugbank.com/drugs/DB14757
    ApprovedWithdrawn

    Agrostis gigantea top is mainly used in allergenic testing.

  7. Drug

    HMI-103

    go.drugbank.com/drugs/DB17684
    Investigational

    HMI-102 is an investigational gene therapy designed to encode the phenylalanine-4-hydroxylase (PAH) gene, mutated in people with phenylketonuria.

  8. Drug

    RCT1100

    go.drugbank.com/drugs/DB18830
    Investigational

    RCT1100 is an investigational mRNA-based therapeutic that aims to treat primary ciliary dyskinesia caused by pathogenic mutations in DNAI1.[L50788]

  9. Drug

    Fludarabine

    go.drugbank.com/drugs/DB01073
    ApprovedInvestigational

    Fludarabine is a chemotherapeutic agent used in the treatment of hematological malignancies. It is commonly marketed under the brand name Fludara.

  10. Drug

    OT-551

    go.drugbank.com/drugs/DB05650
    Investigational

    OT-551 is a novel small molecule that is topically dosed in an eye drop and has the unique ability to penetrate cell membranes and reach both the front and the back of the eye.